Stable Isotope Labeled Compounds Market by Type, Application, End User – Global Forecast to 2022

Summary of the report:

The report “Stable Isotope Labelled Compounds Market by Type (C13, D, 018, N15 label), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital) – Global Forecast to 2022”, The stable isotope-labeled compounds market is expected to reach USD 294.2 Million by 2022 from an estimated USD 254.6 Million in 2017, at a CAGR of 2.94%.The key factors driving the growth of this market include rising proteomics research, increasing research activities in the pharmaceutical and biotechnology sector, and rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds may hinder the growth of this market to a certain extent.

Browse report @

Download PDF @

Objectives of the Study

  • To define, describe, and forecast the global stable isotope labeling market with respect to type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the stable isotope labeling market with respect to four main regions—North America, Europe, Asia-Pacific, and the Rest of the World
  • To profile the key players in the global stable isotope labeling market and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as product launches, approvals, agreements, collaborations, and acquisitions in the global market

Target Audience:

  • Manufacturers of stable isotopes-labeled compounds
  • Distributors of stable isotopes-labelled compounds
  • Healthcare institutions (hospitals and diagnostic centers)
  • Vendors/service providers
  • Research institutes
  • Pharmaceutical and biotechnology companies
  • Research and consulting firms

Scope of the Report:

The research report categorizes the stable isotope-labeled compounds market into the following segments and subsegments:

Stable Isotope-labelled Compounds Market, by Type

  • Carbon-13
  • Nitrogen-15
  • Oxygen-18
  • Deuterium
  • Other Isotopes

Stable Isotope-labeled Compounds Market, by Application

  • Research
  • Clinical Diagnostics
  • Industrial
  • Other Applications

Stable Isotope-labeled Compounds Market, by End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals and Diagnostic Centers
  • Other End Users

Stable Isotope-labeled Compounds Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • RoW
    • Latin America
    • Middle East and Africa

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Rohan
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States

Designed by
Powered by
%d bloggers like this: